𝔖 Bobbio Scriptorium

✦ LIBER ✦

Secukinumab efficacy and safety: Results from the First study of sEcukinumAb in prefilled syringes in subjecTs with chronic plaqUe-type psoriasis REsponse at 12 weeks (FEATURE)

Book ID: 122153510
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 52 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.768

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab efficacy and safety in subje

Secukinumab efficacy and safety in subjects with moderate to severe plaque psoriasis: Results from the Judging the efficacy of secUkinumab in patients with psoriasis using autoiNjector: a Clinical Trial evalUating treatment REsults trial (JUNCTURE)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A 12-week open-label followed by 4-week

A 12-week open-label followed by 4-week double-blind study to determine the safety and efficacy of an extended course of alefacept (LFA-3/igg1 fusion protein) in subjects with chronic plaque psoriasis

✍ Carin H. Gribetz; Robin Blum; Steven Cohen; Mark Lebwohl 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB